Karoline Fechter

Karoline Fechter

Auto-generated profile, based on publicly available information

Karoline Fechter

Division of Biomedical Research, Medical University of Graz, Graz, Austria

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2013 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
AGAkaitz Dorronsoro González
Akaitz Dorronsoro González
IFIzaskun Ferrin
Izaskun Ferrin
JSJuan Manuel Salcedo
Juan Manuel Salcedo
EJEmma Jakobsson
Emma Jakobsson
JFJon Fernández‐Rueda
Jon Fernández‐Rueda
CTCésar Trigueros
César Trigueros
Although mesenchymal stromal cells (MSCs) possess the capacity to modulate immune responses, little is known about the mechanisms that underpin these processes. In this study, we show that immunosupression is mediated by activation of nuclear factor kappa B (NF‐κB) in human MSCs. This pathway is activated by TNF‐α that is generated following TCR stimulation of T cells. Inhibition of NF‐κB through silencing of IκB kinase β or the TNF‐α receptor abolishes the immunosuppressive capacity of MSCs. Our data also indicate that MSC‐associated NF‐κB activation primarily leads to inhibition of T‐cell proliferation with little effect on expression of the activation markers CD69 and CD25. Thus, our data support the hypothesis that the TNF‐α/NF‐κB signalling pathway is required for the initial priming of immunosuppressive function in human MSCs. Interestingly, drugs that interfere with NF‐κB activation significantly antagonise the immunoregulatory effect of MSCs, which could have important implications for immunosuppression regimens in the clinic.

29 September 2013 in Bone Marrow Research
Verified
Journal Article
Open access
PDF file
AGAkaitz Dorronsoro González
Akaitz Dorronsoro González
JFJon Fernández-Rueda
Jon Fernández-Rueda
KFKaroline Fechter
Karoline Fechter
IFIzaskun Ferrin
Izaskun Ferrin
JSJuan Manuel Salcedo
Juan Manuel Salcedo
CTCésar Trigueros
César Trigueros
Mesenchymal stromal cells (MSCs) are multipotent cells found in connective tissues that can differentiate into bone, cartilage, and adipose tissue. Interestingly, they can regulate immune responses in a paracrine way and allogeneic MSCs do not elicit immune response. These properties have encouraged a number of clinical trials in a broad range of regenerative therapies. Although these trials were first focused on their differentiation properties, in the last years, the immunosuppressive features have gained most of the attention. In this review, we will summarize the up-to-date knowledge about the immunosuppressive mechanisms of MSCs in vivo and in vitro and the most promising approaches in clinical investigation.

30 April 2017 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ADAlexander Deutsch
Alexander Deutsch
BRBeate Rinner
Beate Rinner
MPMartin Pichler
Martin Pichler
KPKatharina Prochazka
Katharina Prochazka
KPKatrin Pansy
Katrin Pansy
PNPeter Neumeister
Peter Neumeister
Nuclear orphan receptor NR4A1 exerts an essential tumor suppressor function in aggressive lymphomas. In this study, we investigated the hypothesized contribution of the related NR4A family member NR4A3 to lymphomagenesis. In aggressive lymphoma patients, low expression of NR4A3 was associated with poor survival. Ectopic expression or pharmacological activation of NR4A3 in lymphoma cell lines led to a significantly higher proportion of apoptotic cells. In a mouse NSG xenograft model of lymphoma (stably transduced SuDHL4 cells), NR4A3 expression abrogated tumor growth, compared with vector control and uninduced cells that formed massive tumors. Transcript analysis of four different aggressive lymphoma cell lines overexpressing either NR4A3 or NR4A1 revealed that apoptosis was driven similarly by induction of BAK, Puma, BIK, BIM, BID, and Trail. Overall, our results showed that NR4A3 possesses robust tumor suppressor functions of similar impact to NR4A1 in aggressive lymphomas. Cancer Res; 77(9); 2375–86. ©2017 AACR.

19 December 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
AGAkaitz Dorronsoro González
Akaitz Dorronsoro González
VLV Lang
V Lang
EJE Jakobsson
E Jakobsson
IFI Ferrin
I Ferrin
JSJ M Salcedo
J M Salcedo
CTC Trigueros
C Trigueros
The zinc-finger protein A20 is a key player in the negative feedback regulation of the nuclear factor kappa-light-chain-enhancer of activated B-cell (NF-κB) pathway in response to multiple stimuli. Tumor necrosis factor alpha (TNFα), a cytokine with pleiotropic effects on cellular proliferation and differentiation, dramatically increases A20 expression in all tissues. As TNFα inhibits adipocyte differentiation, we have determined the contribution of A20 to the adipogenic capacity of human mesenchymal stromal cells (MSCs). Here we show that A20 is constitutively expressed in MSCs, which previously has been observed only in cells that are either tumor or immune cells (T/B lymphocytes). TNFα stimulation induced a rapid degradation of A20 protein mediated exclusively by the proteasome in MSCs and not by caspases. This degradation is concomitant to the induction of its own mRNA, which suggests that a tight regulation of NF-κB signaling in MSCs is fundamental. On one hand, we demonstrate that the knockdown of A20-mediated transcript dramatically decreases the adipogenic capacity of MSCs, which correlates with the phenotype observed in the presence of TNFα. On the other hand, A20 overexpression blocks NF-κB activation and drives to increased adipogenesis, even in the presence of TNFα treatment. In conclusion, our data demonstrate that the presence of A20 allows MSCs to differentiate into adipocytes by maintaining NF-κB signaling at a basal state.

15 January 2022 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
BUBarbara Uhl
Barbara Uhl
KPKatharina T Prochazka
Katharina T Prochazka
KFKaroline Fechter
Karoline Fechter
KPKatrin Pansy
Katrin Pansy
HGHildegard T Greinix
Hildegard T Greinix
ADAlexander Deutsch
Alexander Deutsch
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas

28 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KFKaroline Fechter
Karoline Fechter
JFJulia Feichtinger
Julia Feichtinger
KPKatharina Prochazka
Katharina Prochazka
JUJulia Judith Unterluggauer
Julia Judith Unterluggauer
KPKatrin Pansy
Katrin Pansy
ADAlexander Deutsch
Alexander Deutsch
The nuclear orphan receptorNR4A1functions as tumour suppressor in aggressive lymphomas by pro-apoptotic genomic and non-genomic effects. Here, we immunohistochemically studied the clinico-pathological relevance of NR4A1 protein expression patterns in a cohort of 60 diffuse large B cell lymphoma (DLBCL) patients and non-neoplastic lymph nodes. We observed a significant association between high cytoplasmic NR4A1 and favourable cancer-specific survival and the germinal centre B cell-like subtype, respectively. Moreover, the percentage of lymphoma cells exhibiting cytoplasmic NR4A1 significantly correlated to those showing cleaved caspase 3. Complementary, functional profiling using gene set enrichment of Reactome pathways based on publicly available microarray data was applied to determine pathways potentially implicated in cytoplasmic localization of NR4A1 and validated by means of semi quantitative real-time PCR. The pathway analysis revealed changes in the ERK1/2 pathway, and this was corroborated by the finding that high cytoplasmic NR4A1 was associated with higher expression of ERK1/2 targets in our cohort. These data indicate that high cytoplasmic NR4A1 is associated with a favourable lymphoma-specific survival and highlights the importance of NR4A1 expression patterns as potential prognostic marker for risk assessment in aggressive lymphomas.